The influence of the Pro12Ala mutation of the PPAR-gamma receptor gene on metabolic and clinical characteristics in treatment-naäve patients with type 2 diabetes

Diabetes, Obesity and Metabolism

Volumn 4, Issue 6, 2002, Pages 376-378

  Ahluwalia, M ^a   Evans, M ^b   Morris, K ^a   Currie, C ^b   Davies, S ^b   Rees, A ^b   Thomas, A ^a  

^a CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Cholesterol; Glucose; PPAR ; Type 2 diabetes

Indexed keywords

ALANINE; AMINO ACID; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE; RECEPTOR SUBTYPE; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; ENERGY METABOLISM; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN VARIANT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0036847519     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.2002.00230.x     Document Type: Article

References (10)

1. DeFronzo RA. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 1997; 5: 177-270.
2. Haffner SM, Stern MP, Hazuda HP et al. Increased insulin concentrations in non-diabetic offspring of diabetic parents. N Engl J Med 1998; 319: 1297-1301.
3. Spiegelman BM. PPAR-,γ: adipogenic regulator and thiazolidinedione receptor. Diabetes 1998; 47: 507-514.
4. γ2 gene with obesity in two Caucasian populations. Diabetes 1998; 47: 1806-1808.
5. γ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998; 20: 284-287.
6. Chung CJ, Beamer BA, Negri C et al. Molecular scanning of the human peroxisome proliferator activated receptor-γ (hPPAR-γ gene in diabetic caucasians: identification of a Pro12Ala PPAR-γ missense mutation. Biochem Biophys Res Comms 1997; 241: 270-274.
7. Morgan CL, Currie CJ, Peters JR Relationship between diabetes and mortality: a population study using record linkage. Diabetes Care 2000; 23: 1103-1107.
8. Mori Y, Kim-Motoyama H, Katakura T. Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor gamma (2) gene on adiposity, fat distribution, and insulin sensitivity in Japanese men. Biochem Biophys Res Comms 1998; 251 (1): 195-198.
9. Mack WJ, Krauss RM, Hodis HN. Lipoprotein subclasses in the monitored atherosclerosis regression study (MARS): treatment effects and relation to coronary angiographic progression. Arteriosclerosis Thrombosis Vascular Biol 1996; 16 (5): 697-704.
10. Schneider J, Kreuzer J, Hamann A et al. The Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower lipoprotein lipase activity in vivo. Diabetes 2002; 51: 867-870.